iBio Inc

-0.06 (-8.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)132.55M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.25 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$0.72
50-Day MA$0.84
200-Day MA$1.28
See more pivots

iBio Inc Stock, ASE:IBIO

600 Madison Avenue, Suite 1601, New York, New York 10022
United States of America
Phone: +1.302.355.0650
Number of Employees: 75


iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.